Stress, Diurnal Cortisol, and Breast Cancer Survival
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00226967
Verified November 2012 by Stanford University. Recruitment status was: Active, not recruiting
The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.
Condition or disease
The purpose of this study is to investigate stress and tonic activation of diurnal cortisol in aging metastatic breast cancer patients; feedback inhibition & activation of cortisol; and stress-induced phasic activation of cortisol.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
35 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients with recurrent or metastatic breast cancer
Diagnosis of recurrent or metastatic breast cancer.
Karnofsky of 70% or greater.
Proficient enough in English to be able to take questionnaires and participate in the required tasks.
Living within the Greater Bay Area.
Age 35 or older .
Positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis.
Active cancers within the past 10 years other than breast cancer, basal cell or squamous cell carcinomas of the skin, or in situ cancer of the cervix.
Any other serious medical condition that will effect short term survival
History of major psychiatric illness for which patient was hospitalized or medicated, with the exception of depression or anxiety